FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

5 letters match. Newest first.

  1. Olympus Medical Systems Corporation

    FDA warns Olympus over quality-system failures across six medical device plants, including unvalidated designs and released nonconforming devices.

    High risk
  2. Olympus Medical Systems Corp.

    FDA warned Olympus Medical Systems about endoscope accessories for quality-system, complaint, packaging-seal, and reporting failures.

    High risk
  3. Olympus Medical Systems Corporation

    Olympus Medical Systems failed to submit timely Medical Device Reports for endoscope malfunctions, FDA says.

    High risk
  4. Aizu Olympus Co., Ltd.

    Aizu Olympus failed to validate endoscope designs and manufacturing processes and lacked MDR procedures, FDA says.

    High risk
  5. Tianjin Bolang Science-Technology Development Co., Ltd.

    FDA found Tianjin Bolang's otoscopes and rigid endoscopes failed device manufacturing rules after a 2021 inspection and is detaining imports.

    High risk